Tradestie Institutional Equity Comparison Engine

CLSD vs CASI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-02-25 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CASI Overall Edge

CASI Captures Institutional Edge (1โ€“1 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) driven by superior Growth & Margin while CLSD counters with relative strength in Momentum & Technical. Fundamentally, CLSD trades at N/M Forward P/E with -3502.5% operating margin (-80.6% YoY revenue) versus CASI at N/M Forward P/E and -333.1% operating margin (-60.5% YoY). In options structure, CLSD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CASI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CLSD N/M vs CASI N/M Fwd P/E
Growth & Margin Winner CASI
Op Margin -3502.5% vs -333.1% ยท YoY -80.6% vs -60.5%
Momentum & Technical Winner CLSD
1Y -97.5% vs -91.4% ยท 52W Pos 1% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CLSD NASDAQ
Clearside Biomedical, Inc. Common Stock
Pharmaceutical Preparations
$0.41
-26.96% 1D
Market Cap $2.9M
1M Return -88.86%
1Y Return -97.47%
Forward P/E N/M
Unified AI Score
43.3 / 100 HOLD
Tech 40.0 Fund 43.0 Flow 50.0 Mom 40.0
CASI NASDAQ
CASI Pharmaceuticals, Inc. Ordinary Shares
Pharmaceutical Preparations
$0.21
-74.06% 1D
Market Cap $12.4M
1M Return -78.83%
1Y Return -91.43%
Forward P/E N/M
Unified AI Score
44.7 / 100 HOLD
Tech 40.0 Fund 44.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CLSD -97.47% CASI -91.43% Spread: +39.04 pp (CASI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CLSD TTM Op. Margin: -3502.5% CASI TTM Op. Margin: -333.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CLSD vs CASI. Trailing 12-month operating profitability (CLSD -3502.5% vs CASI -333.1%) and valuation multiples (CLSD N/M vs CASI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CLSD (2) vs CASI (5)
Institutional Metric CLSD CASI Criterion Row Winner
Market Capitalization Scale $2.9M $12.4M Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -80.6% -60.5% Higher Growth CASI
Operating Margin (TTM) Profitability -3502.5% -333.1% Higher Margin CASI
Net Profit Margin Profitability 0.0% -184.0% Higher Margin CLSD
Return on Equity (ROE) Capital Efficiency -1310.0% -1094.5% Higher ROE CASI
52-Week Range Position Momentum 1% ($0โ€“$17) 0% ($0โ€“$3) Stronger Trend CLSD
Beta / 30D Volatility Risk Regime 2.24ฮฒ ยท 269% Vol 0.95ฮฒ ยท 240% Vol Lower Realized Risk CASI
Unified Institutional Score Composite Signal 43.3 / 100 (HOLD) 44.7 / 100 (HOLD) Higher Composite CASI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CLSD vs CASI Buy Guide
CLSD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CLSD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CASI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CASI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CLSD nor CASI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.